BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  GRAMINEX Expands Its Partnership With IDIPharma After Clinical Study Publication.

  IDIPharma and Graminex have agreed to expand clinical research on Graminex Flower Pollen Extract.

  October 30, 2017

   · 

  2 min read
• 

  FDA

  NeoLight Wins FDA Nod for Medical Device Poised to Disrupt Newborn Care Market

  Through its empathy-driven innovation model, NeoLight develops technologies that treat infants with life threatening medical conditions.

  October 30, 2017

   · 

  1 min read
• Bio NC

  CMP Pharma Announces That CaroSpir, the First and Only FDA-Approved Spironolactone Oral Suspension, is Now Available

  CaroSpir was approved by the FDA on August 4, 2017 and is now available through normal retail distribution.

  October 30, 2017

   · 

  4 min read
• Business

  Pulmatrix Appoints Dr. James Roach as Chief Medical Officer

  Pulmatrix today announced that it has appointed James (Jim) Roach, MD, FACP, FCCP as its new CMO, effective November 3, 2017.

  October 30, 2017

   · 

  5 min read
• Deals

  Arthrosurface Acquires an Acellular Dermal Technology From WASAS, LLC

  ArthroSurface announced today that it has completed the acquisition of an acellular dermal stabilization device technology, including the intellectual property rights to and associated with this technology, from WASAS, LLC.

  October 30, 2017

   · 

  1 min read
• Business

  CureVac Announces Groundbreaking of Industrial-Scale GMP Production Facility for RNA Therapeutics

  The novel production facility - called GMP IV - will be able to produce approximately 30 million doses of RNA-based therapeutics per year, and is expected to be fully commissioned in 2019.

  October 30, 2017

   · 

  2 min read
• Drug Development

  Can-Fite Announces Enrollment of First Patient in Its ACRobat Phase III Trial of Piclidenoson in Rheumatoid Arthritis

  This randomized, double-blind, active and placebo-controlled study will enroll approximately 500 patients through clinical sites in Europe, Israel and Canada.

  October 30, 2017

   · 

  6 min read
• Business

  Cerveau Technologies Announces a Partnership With Landmark Alzheimer’s Disease DIAN-TU Trial

  The trial will include Cerveau’s MK-6240, an investigational imaging biomarker targeting disease progression.

  October 30, 2017

   · 

  3 min read
• Policy

  NewLink Genetics Announces FDA Orphan-Drug Designation for Indoximod

  Indoximod is aimed at treating patients with Stage IIb-IV melanoma.

  October 30, 2017

   · 

  3 min read
• Drug Development

  Biothera Pharmaceuticals Presents Preclinical Data Showing Imprime PGG Activates Natural Killer Cell-Mediated Tumor Killing

  The data will be presented at the AACR-NCI-EORTC International Conference.

  October 30, 2017

   · 

  2 min read